The Tulane Medical Center is a hospital located in New Orleans, Louisiana. The Tulane Medical Center has centers covering nearly all major specialties of medicine, and is the primary teaching hospital for the Tulane University School of Medicine.

There are 235 beds in Tulane Medical Center.

During the past decade, Tulane Medical Center conducted 107 clinical trials. In the 10-year time frame, 107 clinical trials started and 46 clinical trials were completed, i.e. on average, 43% percent of trials that started reached the finish line to date. In the past 5 years, 50 clinical trials started and 29 clinical trials were completed. i.e. 58% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Tulane Medical Center" #1 sponsor was "University of North Carolina, Chapel Hill" with 18 trials, followed by "Tulane University" with 16 trials sponsored, "National Institute of Allergy and Infectious Diseases (NIAID)" with 13 trials sponsored, "SWOG Cancer Research Network" with 13 trials sponsored and "Children's Oncology Group" with 13 trials sponsored. Other sponsors include 147 different institutions and companies that sponsored additional 100 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Tulane Medical Center" #1 collaborator was "National Cancer Institute (NCI)" with 37 trials as a collaborator, "National Institute of Mental Health (NIMH)" with 18 trials as a collaborator, "National Institute on Drug Abuse (NIDA)" with 17 trials as a collaborator, "Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)" with 8 trials as a collaborator and "National Institute on Alcohol Abuse and Alcoholism (NIAAA)" with 7 trials as a collaborator. Other collaborators include 142 different institutions and companies that were collaborators in the rest 109 trials.

According to Clinical.Site data, the most researched conditions in "Tulane Medical Center" are "HIV Infections" (17 trials), "Cystic Fibrosis" (9 trials), "Atrial Fibrillation" (7 trials), "Breast Cancer" (7 trials) and "HIV Infection" (7 trials). Many other conditions were trialed in "Tulane Medical Center" in a lesser frequency.

Most popular intervention types in "Tulane Medical Center" are "Drug" (152 trials), "Biological" (26 trials), "Other" (21 trials), "Procedure" (17 trials) and "Device" (13 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (31 trials), "cyclophosphamide" (12 trials), "radiation therapy" (11 trials), "IVA" (7 trials) and "carboplatin" (7 trials). Other intervention names were less common.

The vast majority of trials in "Tulane Medical Center" are 192 trials for "All" genders, 18 trials for "Male" genders and 14 trials for "Female" genders.

Currently, there are 58 active trials in "Tulane Medical Center". 1 are not yet recruiting, 33 are recruiting, 21 are Active, not recruiting, and 3 are Enrolling by invitation. In total, there were 131 completed trials in Tulane Medical Center, undefined suspended trials, and 25 terminated clinical trials to date.

Out of the total trials that were conducted in Tulane Medical Center, 18 "Phase 1" clinical trials were conducted, 57 "Phase 2" clinical trials and 78 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 13 trials, and there were also 25 trials that are defined as “Not Applicable".